Sequoia Financial Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Sequoia Financial Advisors, LLC

$8.93 Billion
Q3 2024

A detailed history of Sequoia Financial Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 1,740 shares of REGN stock, worth $1.19 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,740

Previous 1,522 14.32%

Holding current value

$1.19 Million

Previous $1.6 Million 14.38%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$1024.09 - $1201.76 $223,251 - $261,983	218 Added 14.32%	1,740 $1.83 Million
Q2 2024 Jul 15, 2024	BUY	$883.2 - $1071.19 $64,473 - $78,196	73 Added 5.04%	1,522 $1.6 Million
Q1 2024 Apr 30, 2024	SELL	$902.69 - $993.35 $586,748 - $645,677	-650 Reduced 30.97%	1,449 $1.39 Million
Q4 2023 Jan 25, 2024	BUY	$775.18 - $881.7 $697,662 - $793,530	900 Added 75.06%	2,099 $1.84 Million
Q3 2023 Nov 08, 2023	SELL	$692.45 - $844.37 $692 - $844	-1 Reduced 0.08%	1,199 $986,000
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $18,200 - $21,589	-26 Reduced 2.12%	1,200 $862,000
Q1 2023 Apr 24, 2023	BUY	$680.49 - $826.97 $118,405 - $143,892	174 Added 16.54%	1,226 $1.01 Million
Q4 2022 Jan 17, 2023	BUY	$705.89 - $766.39 $471,534 - $511,948	668 Added 173.96%	1,052 $0
Q3 2022 Oct 26, 2022	SELL	$573.97 - $724.32 $53,953 - $68,086	-94 Reduced 19.67%	384 $265,000
Q2 2022 Jul 22, 2022	SELL	$548.35 - $738.84 $9,321 - $12,560	-17 Reduced 3.43%	478 $283,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $55,346 - $64,953	93 Added 23.13%	495 $346,000
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $218,478 - $269,729	402 New	402 $254,000
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $187,626 - $230,244	-420 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $17,697 - $22,495	-37 Reduced 8.1%	420 $203,000
Q3 2020 Oct 23, 2020	SELL	$544.75 - $658.21 $54,475 - $65,821	-100 Reduced 17.95%	457 $256,000
Q2 2020 Aug 25, 2020	BUY	$493.32 - $643.92 $274,779 - $358,663	557 New	557 $347,000
Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $256,033 - $334,194	-519 Closed	0 $347,000
Q1 2020 May 11, 2020	BUY	$336.18 - $494.43 $174,477 - $256,609	519 New	519 $253,000
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $200,474 - $262,702	-559 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $66,001 - $77,112	-153 Reduced 21.49%	559 $250,000
Q2 2017 Aug 09, 2017	BUY	N/A	712	712 $350,000

Others Institutions Holding REGN

# of Institutions

1,497

Shares Held

82.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $73.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.

Account

Sequoia Financial Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History